Assessment of Coronary Artery Calcium Scoring to Guide Statin Therapy Allocation According to Risk-Enhancing Factors The Multi-Ethnic Study of Atherosclerosis

被引:68
作者
Patel, Jaideep [1 ,2 ]
Pallazola, Vincent A. [2 ]
Dudum, Ramzi [2 ]
Greenland, Philip [3 ]
McEvoy, Johnw. [2 ,4 ]
Blumenthal, Roger S. [2 ]
Virani, Salim S. [5 ,6 ]
Miedema, Michael D. [7 ]
Shea, Steven [8 ,9 ]
Yeboah, Joseph [10 ]
Abbate, Antonio [1 ]
Hundley, William G. [1 ]
Karger, Amy B. [7 ]
Tsai, Michael Y. [7 ]
Sathiyakumar, Vasanth [2 ]
Ogunmoroti, Oluseye [2 ]
Cushman, Mary [11 ]
Savji, Nazir [2 ]
Liu, Kiang [3 ]
Nasir, Khurram [2 ,12 ,13 ,14 ]
Blaha, Michael J. [2 ]
Martin, Seth S. [2 ]
Al Rifai, Mahmoud [2 ,6 ]
机构
[1] Virginia Commonwealth Univ, Med Ctr, Div Cardiol, Pauley Heart Ctr, 1200 E Marshall St, Richmond, VA 23298 USA
[2] Johns Hopkins Ciccarone Ctr Prevent Cardiovasc Di, Baltimore, MD USA
[3] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA
[4] Natl Univ Ireland Galway, Natl Inst Prevent & Cardiovasc Hlth, Sch Med, Galway, Ireland
[5] Michael E DeBakey VA Med Ctr, Houston, TX USA
[6] Baylor Coll Med, Dept Med, Sect Cardiol, Houston, TX 77030 USA
[7] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA
[8] Columbia Univ, Dept Med, New York, NY USA
[9] Columbia Univ, Dept Epidemiol, New York, NY USA
[10] Wake Forest Baptist Hlth, Dept Cardiol, Winston Salem, NC USA
[11] Univ Vermont, Div Hematol, Burlington, VT 05405 USA
[12] Houston Methodist DeBakey Heart & Vasc Ctr, Div Cardiovasc Prevent & Wellness, Dept Cardiovasc Med, Houston, TX USA
[13] Houston Methodist DeBakey Heart & Vasc Ctr, Dept Cardiovasc Med, Ctr Cardiovasc Computat & Precis Hlth, Houston, TX USA
[14] Houston Methodist Hosp, Div Hlth Equ & Dispar Res, Ctr Outcomes Res, Houston, TX 77030 USA
关键词
CARDIOVASCULAR-DISEASE; AMERICAN-COLLEGE; CALCIFICATION; MARKERS; ASSOCIATION; EVENTS; MESA; INDIVIDUALS; CHOLESTEROL; IMPACT;
D O I
10.1001/jamacardio.2021.2321
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE The 2018 American Heart Association/American College of Cardiology Guideline on the Management of Blood Cholesterol recommends the use of risk-enhancing factor assessment and the selective use of coronary artery calcium (CAC) scoring to guide the allocation of statin therapy among individuals with an intermediate risk of atherosclerotic cardiovascular disease (ASCVD). OBJECTIVE To examine the association between risk-enhancing factors and incident ASCVD by CAC burden among those at intermediate risk of ASCVD. DESIGN, SETTING, AND PARTICIPANTS The Multi-Ethnic Study of Atherosclerosis is a multi-center population-based prospective cross-sectional study conducted in the US. Baseline data for the present study were collected between July 15, 2000, and July 14, 2002, and follow-up for incident ASCVD events was ascertained through August 20, 2015. Participants were aged 45 to 75 years with no clinical ASCVD or diabetes at baseline, were at intermediate risk of ASCVD (>= 7.5% to <20.0%), and had a low-density lipoprotein cholesterol level of 70 to 189mg/dL. EXPOSURES Family history of premature ASCVD, premature menopause, metabolic syndrome, chronic kidney disease, lipid and inflammatory biomarkers, and low ankle-brachial index. MAIN OUTCOMES AND MEASURES Incident ASCVD over a median follow-up of 12.0 years. RESULTS A total of 1688 participants (mean [SD] age, 65 [6] years; 976 men [57.8%]). Of those, 648 individuals (38.4%) were White, 562 (33.3%) were Black, 305 (18.1%) were Hispanic, and 173 (10.2%) were Chinese American. A total of 722 participants (42.8%) had a CAC score of 0. Among those with 1 to 2 risk-enhancing factors vs those with 3 or more risk-enhancing factors, the prevalence of a CAC score of 0 was 45.7% vs 40.3%, respectively. Over a median follow-up of 12.0 years (interquartile range [IQR], 11.5-12.6 years), the unadjusted incidence rate of ASCVD among those with a CAC score of 0 was less than 7.5 events per 1000 person-years for all individual risk-enhancing factors (with the exception of ankle-brachial index, for which the incidence rate was 10.4 events per 1000 person-years [95% CI, 1.5-73.5]) and combinations of risk-enhancing factors, including participants with 3 or more risk-enhancing factors. Although the individual and composite addition of risk-enhancing factors to the traditional risk factors was associated with improvement in the area under the receiver operating curve, the use of CAC scoring was associated with the greatest improvement in the C statistic (0.633 vs 0.678) for ASCVD events. For incident ASCVD, the net reclassification improvement for CAC was 0.067. CONCLUSIONS AND RELEVANCE In this cross-sectional study, among participants with CAC scores of 0, the presence of risk-enhancing factors was generally not associated with an overall ASCVD risk that was higher than the recommended treatment threshold for the initiation of statin therapy. The use of CAC scoring was associated with significant improvements in the reclassification and discrimination of incident ASCVD. The results of this study support the utility of CAC scoring as an adjunct to risk-enhancing factor assessment to more accurately classify individuals with an intermediate risk of ASCVD who might benefit from statin therapy.
引用
收藏
页码:1161 / 1170
页数:10
相关论文
共 40 条
[1]   2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS) [J].
Aboyans, Victor ;
Ricco, Jean-Baptiste ;
Bartelink, Marie-Louise E. L. ;
Bjorck, Martin ;
Brodmann, Marianne ;
Cohnert, Tina ;
Collet, Jean-Philippe ;
Czerny, Martin ;
De Carlo, Marco ;
Debus, Sebastian ;
Espinola-Klein, Christine ;
Kahan, Thomas ;
Kownator, Serge ;
Mazzolai, Lucia ;
Naylor, A. Ross ;
Roffi, Marco ;
Roether, Joachim ;
Sprynger, Muriel ;
Tendera, Michal ;
Tepe, Gunnar ;
Venermo, Maarit ;
Vlachopoulos, Charalambos ;
Desormais, Ileana .
EUROPEAN HEART JOURNAL, 2018, 39 (09) :763-+
[2]   The Use of Risk-Enhancing Factors to Personalize ASCVD Risk Assessment: Evidence and Recommendations from the 2018 AHA/ACC Multi-Society Cholesterol Guidelines [J].
Agarwala, Anandita ;
Liu, Jing ;
Ballantyne, Christie M. ;
Virani, Salim S. .
CURRENT CARDIOVASCULAR RISK REPORTS, 2019, 13 (07)
[3]   QUANTIFICATION OF CORONARY-ARTERY CALCIUM USING ULTRAFAST COMPUTED-TOMOGRAPHY [J].
AGATSTON, AS ;
JANOWITZ, WR ;
HILDNER, FJ ;
ZUSMER, NR ;
VIAMONTE, M ;
DETRANO, R .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 15 (04) :827-832
[4]   Multi-ethnic study of atherosclerosis: Objectives and design [J].
Bild, DE ;
Bluemke, DA ;
Burke, GL ;
Detrano, R ;
Roux, AVD ;
Folsom, AR ;
Greenland, P ;
Jacobs, DR ;
Kronmal, R ;
Liu, K ;
Nelson, JC ;
O'Leary, D ;
Saad, MF ;
Shea, S ;
Szklo, M ;
Tracy, RP .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 156 (09) :871-881
[5]   Role of Coronary Artery Calcium Score of Zero and Other Negative Risk Markers for Cardiovascular Disease The Multi-Ethnic Study of Atherosclerosis (MESA) [J].
Blaha, Michael J. ;
Cainzos-Achirica, Miguel ;
Greenland, Philip ;
McEvoy, John W. ;
Blankstein, Ron ;
Budoff, Matthew J. ;
Dardari, Zeina ;
Sibley, Christopher T. ;
Burke, Gregory L. ;
Kronmal, Richard A. ;
Szklo, Moyses ;
Blumenthal, Roger S. ;
Nasir, Khurram .
CIRCULATION, 2016, 133 (09) :849-858
[6]   Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study [J].
Blaha, Michael J. ;
Budoff, Matthew J. ;
DeFilippis, Andrew P. ;
Blankstein, Ron ;
Rivera, Juan J. ;
Agatston, Arthur ;
O'Leary, Daniel H. ;
Lima, Joao ;
Blumenthal, Roger S. ;
Nasir, Khurram .
LANCET, 2011, 378 (9792) :684-692
[7]   Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA) [J].
Budoff, Matthew J. ;
Young, Rebekah ;
Burke, Gregory ;
Carr, J. Jeffrey ;
Detrano, Robert C. ;
Folsom, Aaron R. ;
Kronmal, Richard ;
Lima, Joao A. C. ;
Liu, Kiang J. ;
McClelland, Robyn L. ;
Michos, Erin ;
Post, Wendy S. ;
Shea, Steven ;
Watson, Karol E. ;
Wong, Nathan D. .
EUROPEAN HEART JOURNAL, 2018, 39 (25) :2401-+
[8]   Calcified coronary artery plaque measurement with cardiac CT in population-based studies: Standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study [J].
Carr, JJ ;
Nelson, JC ;
Wong, ND ;
McNitt-Gray, M ;
Arad, Y ;
Jacobs, DR ;
Sidney, S ;
Bild, DE ;
Williams, OD ;
Detrano, RC .
RADIOLOGY, 2005, 234 (01) :35-43
[9]   Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney Disease [J].
Chen, Jing ;
Budoff, Matthew J. ;
Reilly, Muredach P. ;
Yang, Wei ;
Rosas, Sylvia E. ;
Rahman, Mahboob ;
Zhang, Xiaoming ;
Roy, Jason A. ;
Lustigova, Eva ;
Nessel, Lisa ;
Ford, Virginia ;
Raj, Dominic ;
Porter, Anna C. ;
Soliman, Elsayed Z. ;
Wright, Jackson T., Jr. ;
Wolf, Myles ;
He, Jiang .
JAMA CARDIOLOGY, 2017, 2 (06) :635-643
[10]   Coronary calcium as a predictor of coronary events in four racial or ethnic groups [J].
Detrano, Robert ;
Guerci, Alan D. ;
Carr, J. Jeffrey ;
Bild, Diane E. ;
Burke, Gregory ;
Folsom, Aaron R. ;
Liu, Kiang ;
Shea, Steven ;
Szklo, Moyses ;
Bluemke, David A. ;
O'Leary, Daniel H. ;
Tracy, Russell ;
Watson, Karol ;
Wong, Nathan D. ;
Kronmal, Richard A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (13) :1336-1345